It was announced on July 24 that the last patient had been dosed for the DM study. And that results would be available within 4-6 weeks. Yes, 6 weeks fell last Friday. They’ve also since come out and announced results will be available the ‘first few weeks’ of Sept.
We are well within any biotech timeframe of which I’m aware.
Plus, we await the 700 proof of concept, as well as ongoing REMAP data... If you glance at p4 of the recent Annual Report, you’ll see that we’re turning into the second last bend of our timeline...
Sept & Oct will be a big months for the company.
General Discussion, page-11
-
- There are more pages in this discussion • 124 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
-0.010(2.20%) |
Mkt cap ! $247.9M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.8¢ | 43.8¢ | $701.3K | 1.564M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 111371 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 8072 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |